-
公开(公告)号：US20250019429A1
公开(公告)日：2025-01-16
申请号：US18892683
申请日：2024-09-23
Applicant: Janssen Biotech, Inc.
Inventor： Kristopher Barnthouse , Subinay Ganguly , Maarten Groeneveld , Manuel Lopez, JR. , Michael Nedved , Kevin D. Smith
IPC: C07K16/24
Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
-
公开(公告)号：US20220153829A1
公开(公告)日：2022-05-19
申请号：US17438657
申请日：2020-02-26
Applicant: Janssen Biotech, Inc.
Inventor： Kristopher Barnthouse , Subinay Ganguly , Maarten Groeneveld , Manuel Lopez , Michael Nedved , Kevin D. Smith
IPC: C07K16/24
Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
-
公开(公告)号：US20250019428A1
公开(公告)日：2025-01-16
申请号：US18765711
申请日：2024-07-08
Applicant: Janssen Biotech, Inc.
Inventor： Kristopher Barnthouse , Subinay Ganguly , Maarten Groeneveld , Manuel Lopez, JR. , Michael Nedved , Kevin D. Smith
IPC: C07K16/24 , A61K39/00 , A61K39/395
Abstract: The present invention relates to methods of manufacture for producing anti-TNF antibodies, e.g., the anti-TNF antibody a recombinant anti-TNF antibody having a heavy chain (HC) comprising amino acid sequence SEQ ID NO:36 and a light chain (LC) comprising amino acid sequence SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
-
公开(公告)号：US20220144934A1
公开(公告)日：2022-05-12
申请号：US17438684
申请日：2020-02-26
Applicant: Janssen Biotech, Inc.
Inventor： Kristopher Barnthouse , Subinay Ganguly , Maarten Groeneveld , Manuel Lopez , Michael Nedved , Kevin D. Smith
IPC: C07K16/24
Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
-
公开(公告)号：US20200291107A1
公开(公告)日：2020-09-17
申请号：US16816814
申请日：2020-03-12
Applicant: Janssen Biotech, Inc.
Inventor： Kristopher Barnthouse , Subinay Ganguly , Maarten Groeneveld , Manuel Lopez , Michael Nedved , Kevin D. Smith
Abstract: Methods of manufacture for producing anti-IL-12/IL-23p40 antibodies, e.g., the anti-IL-12/IL-23p40 antibody ustekinumab, in CHO and specific pharmaceutical compositions of the antibody are useful in treating various diseases.
-
Patent Agency Ranking
公开(公告)号：US20250066465A1
公开(公告)日：2025-02-27
申请号：US18882902
申请日：2024-09-12
Applicant: Janssen Biotech, Inc.
Inventor： Kristopher Barnthouse , Subinay Ganguly , Maarten Groeneveld , Manuel Lopez, JR. , Michael Nedved , Kevin D. Smith
IPC: C07K16/24
Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
-
公开(公告)号：US12180271B2
公开(公告)日：2024-12-31
申请号：US17438702
申请日：2020-02-26
Applicant: Janssen Biotech, Inc.
Inventor： Kristopher Barnthouse , Subinay Ganguly , Maarten Groeneveld , Manuel Lopez, Jr. , Michael Nedved , Kevin D. Smith
IPC: C07K16/24 , A61K39/00 , A61K39/395
Abstract: The present invention relates to methods of manufacture for producing anti-TNF antibodies, e.g., the anti-TNF antibody a recombinant anti-TNF antibody having a heavy chain (HC) comprising amino acid sequence SEQ ID NO:36 and a light chain (LC) comprising amino acid sequence SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
-
公开(公告)号：US20240383976A1
公开(公告)日：2024-11-21
申请号：US18427000
申请日：2024-01-30
Applicant: Janssen Biotech, Inc.
Inventor： Kristopher Barnthouse , Subinay Ganguly , Maarten Groeneveld , Manuel Lopez, JR. , Michael Nedved , Kevin D. Smith
Abstract: Methods of manufacture for producing anti-IL-12/IL-23p40 antibodies, e.g., the anti-IL-12/IL-23p40 antibody ustekinumab, in CHO and specific pharmaceutical compositions of the antibody are useful in treating various diseases.
-
公开(公告)号：US12129292B2
公开(公告)日：2024-10-29
申请号：US17438657
申请日：2020-02-26
Applicant: Janssen Biotech, Inc.
Inventor： Kristopher Barnthouse , Subinay Ganguly , Maarten Groeneveld , Manuel Lopez , Michael Nedved , Kevin D. Smith
IPC: C07K16/24
CPC classification number: C07K16/241 , C07K2317/14 , C07K2317/33 , C07K2317/41 , C07K2317/565 , C07K2317/567 , C07K2317/732 , C07K2317/76 , C07K2317/92
Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
-
公开(公告)号：US12122825B2
公开(公告)日：2024-10-22
申请号：US17438684
申请日：2020-02-26
Applicant: Janssen Biotech, Inc.
Inventor： Kristopher Barnthouse , Subinay Ganguly , Maarten Groeneveld , Manuel Lopez, Jr. , Michael Nedved , Kevin D. Smith
IPC: C07K16/24
CPC classification number: C07K16/241 , C07K2317/14 , C07K2317/21 , C07K2317/34 , C07K2317/41 , C07K2317/567 , C07K2317/76 , C07K2317/92
Abstract: Presented here are methods for producing a recombinant anti-TNF antibody having a heavy chain (HC) comprising SEQ ID NO:38 and a light chain (LC) comprising SEQ ID NO:37 and compositions comprising the recombinant anti-TNF antibody.
-
-
-
-
-
-
-
-
-
Search Results
11
records
(took 0.02 seconds)
